Acute appendicitis, inflammatory appendiceal mass and the risk of a hidden malignant tumor: A systematic review of the literature

World Journal of Emergency Surgery

Volumn 12, Issue 1, 2017, Pages

  Teixeira, Frederico José Ribeiro ^a   do Couto Netto, Sérgio Dias ^a,b   Akaishi, Eduardo Hiroshi ^a   Utiyama, Edivaldo Massazo ^a   Menegozzo, Carlos Augusto Metidieri ^a   Rocha, Marcelo Cristiano ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Emergency Surgical Service ^*  (Brazil)

Author keywords

Acute appendicits; Appendiceal inflammatory mass; Appendiceal neoplasms; Appendiceal neuroendocrine tumors; Interval appendectomy; Pseudomixoma peritonei

Indexed keywords

EID: 85014772491     PISSN: None     EISSN: 17497922     Source Type: Journal    
DOI: 10.1186/s13017-017-0122-9     Document Type: Review

References (64)

1. McBurney C. Experience with early operative interference in cases of disease of the vermiform appendix. N Y Med J. 1889;50:676-84.
2. De Frances CJ, Cullen KA, Kozak LJ. National Hospital Discharge Survey: 2005 annual summary with detailed diagnosis and procedure data. Vital Health Stat. 2007;1:209.
3. Buckius MT. Changing epidemiology of acute appendicitis in the United States: study period 1993-2008. J Surg Res. 2012;175:185-90.
4. Andersson RE. Nonsurgical treatment of appendiceal abscess or phlegmon: a systematic review and meta- analysis. Ann Surg. 2007;246:741-8.
5. Collins DC. 71,000 human appendix specimens. A final report, summarizing forty years of study. Am J Proctol. 1963;14:265-81.
6. Livingston EH. Disconnect between incidence of nonperforated and perforated appendicitis: implications for pathophysiology and management. Ann Surg. 2007;245:886-92.
7. Connor SJ. Appendiceal tumors: retrospective clinicopathologic analysis of appendiceal tumors from 7,970 appendectomies. Dis Colon Rectum. 1998;41:75-80.
8. Wright GP. Is there truly an oncologic indication for interval appendectomy? Am J Surg. 2015;209:442-6.
9. Deelder JD. How to treat an appendiceal inflammatory mass: operatively or nonoperatively? J Gastrointest Surg. 2014;18:641-5.
10. Misdraji J. Appendiceal mucinous neoplasms: controversial issues. Arch Pathol Lab Med. 2010;134:864-70.
11. Carpenter S. Increased risk of neoplasm in appendicitis treated with interval appendectomy: single-institution experience and literature review. Am Surg. 2012;78:339-43.
12. Lee WS. A retrospective clinicopathological analysis of appendiceal tumors from 3,744 appendectomies: a single-institution study. Int J Colorectal Dis. 2011;26:617-21.
13. Lai HW. Interval appendectomy after conservative treatment of an appendiceal mass. World J Surg. 2006;30:351-7.
14. Furman MJ. Increased risk of mucinous neoplasm of the appendix in adults undergoing interval appendectomy. JAMA Surg. 2013;148(8):703-6.
15. Cerame MA. A 25-year review of adenocarcinoma of the appendix a frequently perforating carcinoma. Dis Colon Rectum. 1988;31(2):145-50.
16. Tingstedt B. Management of appendiceal masses. Eur J Surg. 2002;168:579-82.
17. McCusker ME. Primary malignant neoplasms of the appendix: a population-based study from the Surveillance, Epidemiology and End-Results program, 1973-1998. Cancer. 2002;94:3307-12.
18. Roberts JK. Macroscopic findings at appendicectomy are unreliable: implications for laparoscopy and malignant conditions of the appendix. Int J Surg Pathol. 2008;16(4):386-90.
19. Turaga KK, Pappas SG, Gamblin T. Importance of histologic subtype in the staging of appendiceal tumors. Ann Surg Oncol. 2012;19:1379-85.
20. Oberndorfer S. Karzinoide Tumoren des Dünndarms. Frankf Z Pathol. 1907;1:426.
21. Ellis L. Carcinoid tumors of the gastrointestinal tract: trends in incidence in England since 1971. Am J Gastroenterol. 2010;105:2563-9.
22. Hauso O. Neuroendocrine tumor epidemiology: contrasting Norway and North America. Cancer. 2008;113:2655-64.
23. Quaedvlieg PF. Epidemiology and survival in patients with carcinoid disease in the Netherlands. An epidemiological study with 2,391 patients. Ann Oncol. 2001;12:1295-300.
24. Perez EA. 7,201 carcinoids: increasing incidence overall and disproportionate mortality in the elderly. World J Surg. 2007;31:1022-30.
25. Moertel CG. Carcinoid tumors of the vermiform appendix. Cancer. 1968;21:270-8.
26. Groth SS. Appendiceal carcinoid tumors: predictors of lymph node metastasis and the impact of right hemicolectomy on survival. J Surg Oncol. 2011;103:39-45.
27. García-Carbonero R. Incidence, patterns of care and prognostic factors for outcome of gastro-enteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE). Ann Oncol. 2010;21:1794-803.
28. Lepage C. Incidence and management of primary malignant small bowel cancers: a well-defined French population study. Am J Gastroenterol. 2006;101:2826-32.
29. Ploeckinger U. The German NET registry: an audit on the diagnosis and therapy of neuroendocrine tumours. Neuroendocrinology. 2009;90:349-63.
30. Sandor A. A retrospective analysis of 1570 appendiceal carcinoids. Am J Gastroenterol. 1998;93:422-8.
31. Stinner B. Neuroendocrine tumours (carcinoids) of the appendix. Best Pract Res Clin Gastroenterol. 2005;19:729-38.
32. O'Donnell ME. Malignant neoplasms of the appendix. Int J Colorectal Dis. 2007;22:1239-48.
33. Prommegger R. Retrospective evaluation of carcinoid tu- mors of the appendix in children. World J Surg. 2002;26:1489-92.
34. Parkes SE. Carcinoid tumours of the appendix in children 1957-1986: incidence, treatment and out- come. Br J Surg. 1993;80:502-4.
35. In't Hof KH. Carcinoid tumour of the appendix: an analysis of 1,485 consecutive emergency appendectomies. J Gastrointest Surg. 2008;12:1436-8.
36. Fornaio R. Appendectomy or right hemicolectomy in the treatment of appendiceal carcinoid tumors? Tumori. 2007;93:587-90.
37. Moertel CG. Carcinoid tumor of the appendix: treat- ment and prognosis. N Engl J Med. 1987;317:1699-701.
38. Bamboat ZM. Is right hemicolectomy for 2.0-cm appendiceal carcinoids justified? Arch Surg. 2006;141:349-52.
39. Alexandraki KI. Clinical value of right hemicolectomy for appendiceal carcinoids using pathologic criteria. J Endocrinol Invest. 2011;34:255-9.
40. Rossi G. Does mesoappendix infiltration predict a worse prognosis in incidental neuroendocrine tumors of the appendix? A clinicopathologic and immunohistochemical study of 15 cases. Am J Clin Pathol. 2003;120:706-11.
41. Dunn JP. Carcinoid tumours of the appendix: 21 cases, with a review of the literature. NZ Med J. 1982;95:73-6.
42. McGory ML. Malignancies of the appendix: beyond case series reports. Dis Colon Rectum. 2005;48:2264-71.
43. Landry CS. Analysis of 900 appendiceal carcinoid tumors for a proposed predictive staging system. Arch Surg. 2008;143:664-70.
44. O'Donnell ME. Surgical treatment of malignant carcinoid tumours of the appendix. Int J Clin Pract. 2007;61:431-7.
45. Toumpanakis C. Goblet cell carcinoid tumors (adeno- carcinoid) of the appendix. Dis Colon Rectum. 2006;50:315-22.
46. Pahlavan PS. Goblet cell carcinoid of the appendix. World J Surg Oncol. 2005;3:36.
47. Roy P. Goblet cell carcinoid tumors of the appendix: an overview. World J Gastrointest Oncol. 2010;2(6):251-8.
48. Tang LH. Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix. Am J Surg Pathol. 2008;32:1429-43.
49. Chang P. Adenocarcinoma of the appendix. Dis Colon Rectum. 1981;24:176-80.
50. Cortina R. Management and prognosis of adenocarcinoma of the appendix. Dis Colon Rectum. 1995;38:848-52.
51. Deans GT. Neoplastic lesions of the appendix. Br J Surg. 1995;82:299-306.
52. Gustafsson B. Uncommon cancers of the small intes- tine, appendix and colon: an analysis of SEER 1973-2004, and current diagnosis and therapy. Int J Oncol. 2008;33:1121-31.
53. Ronnett BM. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei". Am J Surg Pathol. 1995;19(12):1390-408.
54. Panarelli NC. Mucinous neoplasms of the appendix and peritoneum. Arch Pathol Lab Med. 2011;135:1261-8.
55. Yantiss RK. Prognostic significance of localized extra-appendiceal mucin deposition in appendiceal mucinous neoplasms. Am J Surg Pathol. 2009;33(2):248-55.
56. Carr NJ. Tumours of the appendix. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. WHO classification of tumours of the digestive system, vol. 3. 4th ed. Lyon: IARC Press; 2010. p. 122-5. World Health Organization Classification of Tumours.
57. Edge SB. AJCC cancer staging manual. 7th ed. New York: Springer; 2010. p. 133-41.
58. Carr NJ. Epithelial noncarcinoid tumors and tumor-like lesions of the appendix: a clinicopathologic study of 184 patients with a multivariate analysis of prognostic factors. Cancer. 1995;75(3):757-68.
59. Miner TJ. Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg. 2005;241(2):300-8.
60. Moran B. Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei). J Surg Oncol. 2008;98(4):277-82.
61. Chua TC. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30(20):2449-56.
62. Benedix F. Primary appendiceal carcinoma e Epidemiology, surgery and survival: Results of a German multi-center study. EJSO. 2010;36:763e771.
63. Nitecki SS. The natural history of surgically treated primary adenocarcinoma of the appendix. Ann Surg. 1994;219:51-7.
64. Lieu CH. Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix. Ann Oncol. 2012;23:652-8.